Topic Archives: Klebsiella

Comments

  • Avatar

    Re: Klebsiella plague promo from Alliance for Advanced Health.... This promo appeared in my inbox today. "Doc Gumsho...

  • Avatar

    Join the discussion I already have Uncensored Health 25 Forbidden Cures You Can Have Today from Alliance for Advanced He...

  • Avatar

    Ok, hey there Gumshoe. This is my area... Incredible the amount of hogwash out there... First, a high percentage of ...

  • Avatar

    A friend had Klebsiella last summer. We think she got it on a road trip from NY to FL. As she is allergic to penicillin ...

  • Avatar

    $AKAO $Shionogo $CRE $cUTI Hi dan: the most recent safety AND efficacy data of cefiderocol were presented about th...

  • achandra13

    $AKAO Wow! Whats there not to like from the corporate update? -The U.S. Food and Drug Administration (FDA) granted Br...

  • SoGiAm

    $AKAO long - Achaogen Initiates C-Scape Clinical Development Program with Phase 1 Study of Orally-Administered Antiba...

  • Avatar

    $AKAO long. Some additional detail: Following the meeting, the presentation slides and posters will be available on the...

  • Avatar

    WHO (World Health Organisation) today announced a list of bacteria for which antibiotics are urgently needed: http:/...

  • Avatar

    I found a great report from the American Chemical Society that profiles promising new drugs in the pipelines of biotechs...

  • SoGiAm

    $AKAO - Achaogen's Plazomicin Highlighted in Multiple Presentations at ASM Microbe 2016 Outlining Bactericidal Activity ...

  • Avatar

    $AKAO Achaogen has been going crazy on that pre-clinical research. The company is presenting 4 posters and 2 oral pre...

  • Avatar

    AKAO mentioned in this Barons article today about the big need for Antibiotics in the EU. EU Needs New Drugs to Fi...

  • Dr. KSS, MD PhD

    I am glad to see this interview, to know it's out there, but it is definitely a softball-lobbing session, One wonders if...

  • Dr. KSS, MD PhD

    Matt: I am favorable on it. Not much in it is new, but given the dearth and sloth of so many biotechs as regards providi...

  • DBMD

    Strange about AKAO, Carbapenem-resistant Enterobacteriaceae (CRE) Klebsiella species and Escherichia coli (E. coli) ar...

  • Avatar

    Thank you Dr KSS. I have an active interest on this klebsiella thing, because mine youngest has gotten infected with it,...

  • Dr. KSS, MD PhD

    http://www.stockgumshoe.com/2014/06/microblog-is-this-red-hot-new-blood-stock-any-bloody-good-as-an-investment/#comment-...

  • Avatar

    Serendipity at large. When you click on the aforementioned link, you find this post on Reuters: How to fix an broken ma...

  • Dr. KSS, MD, PhD

    I am catching up on reading posts after a busy few days. Any companies that people have brought up for discussion, maybe...

  • Dr. KSS, MD PhD

    Glenn: I reiterate being long and convicted about CTIX. IN one of the other threads, Linda Kulow posted a clipping, a ne...

  • Avatar

    Thank you, Dr. K, that's a little disappointing I was hoping it was good news. I'm not familiar with Klebsiella (big s...

  • Dr. KSS, MD PhD

    Linda: Thanks for posting that update on CTIX. I have to note, however, that I do not understand why they would make a p...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch